Infleqtion CTO granted 2.34M shares, new options

Infleqtion, Inc. (formerly Churchill Capital Corp X) Chief Technology Officer Pranav Gokhale reported equity awards received on February 13, 2026.

Rhea-AI Filing Summary

Infleqtion, Inc. (formerly Churchill Capital Corp X) Chief Technology Officer Pranav Gokhale reported equity awards received on February 13, 2026. He acquired 2,338,980 shares of common stock at a price of $0.00 per share, plus stock options covering an additional 559,367 shares. Some options are already vested, while others vest in equal monthly installments beginning on February 17, 2026, subject to continued service. Several of these awards reflect legacy ColdQuanta equity that was converted into Infleqtion stock and options in connection with the company’s merger transaction.

Insider Trade Summary

Grant/Award: 2,898,347 shares

Grant/Award 6 txns

Insider Gokhale Pranav

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	260,552	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	347	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	3,859	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	781	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	293,828	$0.00	$0.00
Grant/Award	Common Stock	2,338,980	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 559,367 contracts (Direct); Common Stock — 2,338,980 shares (Direct)

Footnotes (5)

1. F1. Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").
2. F2. 50% of the stock option vested and became exercisable on May 10, 2024, and thereafter the remainder vest in 24 equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
3. F3. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.
4. F4. Fully vested.
5. F5. 1/48th of the shares underlying the option vest in equal monthly installments commencing on February 17, 2026, subject to the Reporting Person's continued service through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Infleqtion CTO Pranav Gokhale report for CCCX?

Pranav Gokhale reported equity awards, not open-market trades. He was granted 2,338,980 shares of Infleqtion common stock at $0.00 per share and stock options over 559,367 shares, reflecting compensation and merger-related equity conversion rather than buying shares in the market.

How many Infleqtion (CCCX) common shares did the CTO receive?

He received 2,338,980 Infleqtion common shares as a grant at $0.00 per share. This award represents compensation and merger-related consideration, increasing his direct ownership without cash outlay, rather than a purchase of stock on the open market.

What stock options were granted to the Infleqtion CTO in this Form 4?

He was granted stock options covering a total of 559,367 shares. These options were reported across several line items and include both converted legacy ColdQuanta options and new Infleqtion options, with varying vesting schedules tied to his continued employment and service.

Are the Infleqtion CTO’s new stock options immediately vested?

Vesting is mixed. One footnote states certain options are fully vested, while another explains that one grant vests in 48 equal monthly installments starting February 17, 2026, contingent on his continued service with Infleqtion on each monthly vesting date.

How is the Churchill Capital–ColdQuanta merger related to these Infleqtion awards?

The filing explains that legacy ColdQuanta options were automatically converted into Infleqtion options under a merger agreement. Churchill Capital Corp X combined with ColdQuanta in a series of mergers, after which the acquiror was renamed Infleqtion, Inc., and the converted awards kept their original terms.

Did the Infleqtion CTO buy or sell any shares for cash in this Form 4?

He did not report any cash purchases or sales. All transactions are coded as grants or other acquisitions at $0.00 per share, representing compensation and equity converted in the merger, rather than discretionary open-market trading activity in Infleqtion stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 08:44 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gokhale Pranav

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE CO 80027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Churchill Capital Corp X/Cayman [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		A(1)		2,338,980	A	$0(1)	2,338,980	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.67	02/13/2026		A(1)		260,552		(2)	08/25/2032	Common Stock	260,552	(3)	260,552	D
Stock Option (Right to Buy)	$0.67	02/13/2026		A(1)		347		(4)	05/30/2033	Common Stock	347	(3)	347	D
Stock Option (Right to Buy)	$0.9	02/13/2026		A(1)		3,859		(4)	03/10/2034	Common Stock	3,859	(3)	3,859	D
Stock Option (Right to Buy)	$0.9	02/13/2026		A(1)		781		(4)	06/05/2034	Common Stock	781	(3)	781	D
Stock Option (Right to Buy)	$13.22	02/13/2026		A		293,828		(5)	02/12/2036	Common Stock	293,828	$0	293,828	D

Explanation of Responses:

1. Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").

2. 50% of the stock option vested and became exercisable on May 10, 2024, and thereafter the remainder vest in 24 equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

3. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.

4. Fully vested.

5. 1/48th of the shares underlying the option vest in equal monthly installments commencing on February 17, 2026, subject to the Reporting Person's continued service through each vesting date.

	/s/ Jason D. Hall, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.